My bookmarksSign up free

2011/73/EU: Commission Decision of 2 February 2011 authorising the placing on the market of a mycelial extract from Lentinula edodes (Shiitake mushroom) as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2011) 442)

2011/73/EU: Commission Decision of 2 February 2011 authorising the placing on the market of a mycelial extract from Lentinula edodes (Shiitake mushroom) as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2011) 442)

Regulation (EC) No 258/97 · Decision · 5 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

The mycelial extract from Lentinula edodes as specified in Annex I may be placed on the market in the Union as a novel food ingredient for the uses listed in Annex II.

Article 2

The designation of the mycelial extract from Lentinula edodes authorised by this Decision on the labelling of the foodstuff containing it shall be ‘extract from the mushroom Lentinula edodes ’ or ‘extract from the Shiitake mushroom’.

Article 3

This Decision is addressed to GlycaNova Norge AS, Oraveien 2, 1630 Gamle Fredrikstad, Norway.

Supplementary provisions

ANNEX ISupplementary provisions

ANNEX I Specifications of the mycelial extract from Lentinula edodes Description: The novel food ingredient is a sterile aqueous extract obtained from the mycelium of Lentinula edodes cultivated in a submerged fermentation. It is a light brown, slightly turbid liquid. Lentinan is a β-(1-3) β-(1-6)-D-glucan which has a molecular weight of approximately 5 × 10 5 Daltons, a degree of branching of 2/5 and a triple helical tertiary structure. Composition of the mycelial extract from Lentinula edodes Moisture 98  % Dry matter 2  % Free glucose less than 20 mg/ml Total Protein  ( *1 ) less than 0,1 mg/ml N-containing constituents  ( *2 ) less than 10 mg/ml Lentinan 0,8 – 1,2 mg/ml ( *1 )   Bradford method ( *2 )   Kjeldahl method

ANNEX IISupplementary provisions

ANNEX II Uses of the mycelial extract from Lentinula edodes Use group Maximum level of mycelial extract from Lentinula edodes Bread products 2 ml/100 g Soft drinks 0,5 ml/100 ml Ready prepared meals 2,5 ml per meal Foods based on yoghurt 1,5 ml/100 ml Food supplements (as defined in Directive 2002/46/EC  ( 1 ) ) 2,5 ml per day dose ( 1 )    OJ L 183, 12.7.2002, p. 51 .

Other acts of the same type
Commission Implementing Decision (EU) 2026/1797 of 16 July 2026 amending Implementing Decision (EU) 2026/1108 concerning certain emergency measures relating to sheep pox and goat pox in Romania (notified under document C(2026) 2516)Council Decision (CFSP) 2026/1804 of 16 July 2026 amending Decision 2014/512/CFSP concerning restrictive measures in view of Russia’s actions destabilising the situation in UkrainePolitical and Security Committee Decision (CFSP) 2026/1884 of 16 July 2026 on the reconfirmation of the authorisation of the European Union military operation in the Mediterranean (EUNAVFOR MED IRINI) (EUNAVFOR MED IRINI/3/2026)Political and Security Committee Decision (CFSP) 2026/1886 of 16 July 2026 on the appointment of the head of the military command and support cell of the European Union Security and Defence Initiative in support of West African countries of the Gulf of Guinea, and repealing Decision (CFSP) 2026/58 (EUSDI/1/2026)Commission Decision of 15 July 2026 on the compatibility with Union law of measures to be taken by Slovenia pursuant to Article 14(1) of Directive 2010/13/EU of the European Parliament and of the CouncilCommission Implementing Decision (EU) 2026/1736 of 14 July 2026 on harmonised standards for digital product passports drafted in support of Regulation (EU) 2024/1781 of the European Parliament and of the CouncilCouncil Decision (EU) 2026/1742 of 14 July 2026 on the conclusion of the Interim Agreement on Trade between the European Union and the United Mexican StatesCommission Implementing Decision (EU) 2026/1746 of 14 July 2026 amending Implementing Decision (EU) 2025/1160 concerning certain emergency measures relating to sheep pox and goat pox in Bulgaria (notified under document C(2026) 5033)Commission Implementing Decision (EU) 2026/1759 of 14 July 2026 amending Implementing Decision (EU) 2024/2207 concerning certain emergency measures relating to sheep pox and goat pox in Greece (notified under document C(2026) 5059)Commission Implementing Decision (EU) 2026/1765 of 14 July 2026 amending the Annexes to Implementing Decision (EU) 2025/1582 concerning certain emergency measures relating to infection with lumpy skin disease virus in Italy (notified under document C(2026) 5039)Decision (EU) 2026/1769 of the European Parliament and of the Council of 14 July 2026 empowering Austria to amend its bilateral road transport agreement with Switzerland with a view to authorising cabotage operations in the course of the provision of international passenger transport services by coach and bus in the border regions between the two countriesPolitical and Security Committee Decision (CFSP) 2026/1781 of 14 July 2026 on the appointment of the Head of Mission of the European Union Rule of Law Mission in Kosovo (EULEX KOSOVO) (EULEX KOSOVO/2/2026)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next